<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02397109</url>
  </required_header>
  <id_info>
    <org_study_id>ALR_2015-1</org_study_id>
    <nct_id>NCT02397109</nct_id>
  </id_info>
  <brief_title>mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)</brief_title>
  <acronym>DDX</acronym>
  <official_title>Study Of The Agreement Between The mDixon TSE Sequence And Conventional MRI Sequences In The Evaluation Of Dysimmune Orbitopathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The dysthyroid orbitopathy (DO) is a chronic disease, evolving during 2 to 3 years, with a&#xD;
      hypertrophy and a variable degree of inflammation of the eyelid muscles, the oculomotor&#xD;
      muscles and the orbital fat.&#xD;
&#xD;
      If the diagnosis of OD is primarily clinical and laboratory, MRI is an additional&#xD;
      contribution to the clinic, guiding the therapeutic management by detecting inflammatory&#xD;
      lesions not found on clinical examination in 1/3 of cases.&#xD;
&#xD;
      The three MRI sequences conventionally practiced ((T2, T2-fat-sat, T1) allow muscles signal&#xD;
      analysis oculomotor abnormalities as well as the orbital fat.&#xD;
&#xD;
      Compared to these sequences, the main advantage sequences DIXON is a faster acquisition. In&#xD;
      addition, DIXON type of imaging overcomes most of these artifacts and to obtain a homogeneous&#xD;
      fat removal.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 4, 2015</start_date>
  <completion_date type="Actual">September 2020</completion_date>
  <primary_completion_date type="Actual">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment, by the determination of the Cohen's kappa coefficient, of the concordance between the conventional sequences (T1, T2, T2-fat-sat) and the mDIXON sequence for the diagnosis of inflammatory or non-inflammatory dysthyroid orbitopathy.</measure>
    <time_frame>One hour</time_frame>
  </primary_outcome>
  <enrollment type="Actual">294</enrollment>
  <condition>Dysthyroid Ophthalmopathies</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a dysthyroid orbitopathy undergoing a MRI&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged 18 to 90 years, suffering from thyroid dysfunction proved by clinical and&#xD;
             laboratory tests, with a bilateral clinical dysthyroid orbitopathy and undergoing an&#xD;
             eye MRI&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Absolute or relative contra-indication to MRI or to a contrast agent gadolinium&#xD;
             injection (including pregnant or likely to be, breastfeeding women)&#xD;
&#xD;
          -  Patient under guardianship&#xD;
&#xD;
          -  Patient not willing to participate.&#xD;
&#xD;
          -  Lack of affiliation to social security or medical state aid (AME) or universal health&#xD;
             coverage (CMU)&#xD;
&#xD;
          -  Motion artifact on the sequences, not corrected by the repeat sequences&#xD;
&#xD;
          -  Metal artifact prohibiting the analysis of the region of interest&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 19, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Graves Ophthalmopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

